Back to Journals » OncoTargets and Therapy » Volume 15

Snake Venom Causes Apoptosis by Increasing the Reactive Oxygen Species in Colorectal and Breast Cancer Cell Lines [Corrigendum]

Authors Al-Asmari AK, Riyasdeen A, Al-Shahrani MH, Islam M

Received 11 October 2022

Accepted for publication 11 October 2022

Published 26 October 2022 Volume 2022:15 Pages 1289—1290

DOI https://doi.org/10.2147/OTT.S393043



Al-Asmari AK, Riyasdeen A, Al-Shahrani MH, Islam M. Onco Targets Ther. 2016;9:6485-6498.

It was bought to the authors attention that the images in Figure 1A, panel V1 and V2 (10 µg/mL) were duplicated. The error was introduced inadvertently at the time of figure assembly. The authors wish to apologize for this oversight and for any inconveniences caused.

The correct Figure 1 is as follows.

Figure 1 Clonogenic assay.

Notes: Anchorage-dependent colony formation assay shows a significant reduction in colony formation in (A) HCT-8 and (B) MDA-MB-231 cell lines when treated with different concentrations of snake venoms. Quantitative analyses are given in the form of bar graphs for HCT-8 (C) and MDA-MB-231 (D). A significant decrease in the colony formation is evident. “V” followed by numbers represents the specific venom, V1, V2, V3, and V4 are the venoms obtained from the species of the snakes, namely Bitis arietans, Cerastes gasperettii, Echis coloratus, and Echis pyramidum, respectively. *Statistically significant values (P<0.05).


Read the original article


Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.